Newsroom

February 19th 2021

Melbourne team moves towards human trials of bionic eye

A cortical vision device that helps restore sight to the blind may go to human trial within five years. The ground-breaking...

February 16th 2021

Australian company develops three-minute COVID breath test

An Australian company says it has developed a three-minute COVID-19 breath test and is seeking government funding for...

February 16th 2021

TALi raises $3.85m for global partnership rollout

TALi Digital Limited (ASX:TD1) (TALi or the Company), a leading digital health business is pleased to advise that it has...

Blog

The game-changing breathalyser that will determine just how infectious a person tested for COVID-19 may be

February 18th 2021

The game-changing breathalyser that will determine just how infectious a person tested for COVID-19 may be

There is huge interest in the latest developments from GreyScan with fantastic coverage here and overseas for news of the...
GreyScan TVD-2

February 11th 2021

GreyScan TVD-2

CEO Samantha Ollerton tells us about the gap that can be filled by GreyScan's Trace Virus Detection solution for people...
GreyScan ETD-100

February 4th 2021

GreyScan ETD-100

The deadly attack on the US Capitol in Washington on January 6 highlights the need for portable and robust security equipment...

Partners

Research Institute Global & Channel Partners

Cochlear
Royal Eye and Ear Hospital
University of Melbourne
Australian Research Council
HP Invent
IBM
Monash University
The Alfred Hospital
St Vincents Hospital
Monash Vision Group
DZNE
Eastern Health
State Government of Victoria
Charles Sturt University
Department of the Prime Minister and Cabinet
Australian National University
Global Kinetics
National Health and Medical Research Council
Nanosonics
CSIRO
UTAS
Swinbourne
ResMed
TMS
Bosch
Fraunhofer
Siemens
Intel
PMHC
Peter Mac
Telstra Eureka